We are live on ! Find out more
VIVS icon

VivoSim Labs
VIVS

25 hedge funds and large institutions have $110K invested in VivoSim Labs in 2026 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more capital inflows, than outflows

Capital inflows: $53.7K | Capital outflows: $48.5K

0.21% more ownership

Funds ownership: 3.75% → 3.96% (+0.21%)

0% more funds holding

Funds holding: 25 → 25 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

60% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 5

Holders
25
Holders Change
–
Holders Change %
0%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$24.9K
2
HRT Financial
HRT Financial
New York
+$24.6K
3
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
+$3.95K
4
FNY Investment Advisers
FNY Investment Advisers
New York
+$269
5
Caitong International Asset Management
Caitong International Asset Management
Hong Kong
+$19

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$23K
2
Geode Capital Management
Geode Capital Management
Massachusetts
-$14.6K
3
Citigroup
Citigroup
New York
-$9.3K
4
UBS Group
UBS Group
Switzerland
-$1.26K
5
Allworth Financial
Allworth Financial
California
-$298

VIVS Hedge Fund Activity: Q2 2026 in Review

25 of the 8,376 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q2 2026, worth a combined $110K — down 22% from $140K a quarter earlier.

Fund positioning in VIVS was balanced in Q2 2026: 4 funds opened new positions, 4 closed out, 2 added to existing stakes and 5 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $24.9K. The largest seller was Goldman Sachs, exiting entirely with an estimated $23K sold.

  • 25 institutional investors held VivoSim Labs (VIVS) as of Q2 2026, unchanged from Q1 2026.
  • Funds reported $110K of VivoSim Labs stock for Q2 2026, down 22% quarter-over-quarter.
  • 4 funds opened new VivoSim Labs positions in Q2 2026 and 4 closed out, a net change of 0 holders.
  • The largest VivoSim Labs buyer in Q2 2026 was Renaissance Technologies, an estimated $24.9K added.
  • The largest VivoSim Labs seller in Q2 2026 was Goldman Sachs, an estimated $23K sold.

Based on aggregated 13F filings for Q2 2026.